For citations:
Zelberg M.A., Mironov N.Yu., Dzaurova Kh.M., Yuricheva Yu.A., Maykov E.B., Novikov P.S., Gagloeva D.A., Krimukova M.A., Sokolov S.F., Golitsyn S.P. Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation. Eurasian heart journal. 2024;(2):86-95. (In Russ.) https://doi.org/10.38109/2225-1685-2024-2-86-95